Nouscom Raises €67.5 million ($72 million) in Oversubscribed Series C Financing Round
14. November 2023 01:00 ET
|
Nouscom Srl
New specialist European and US life sciences investors join existing investors to enable Nouscom to continue advancing the clinical development of its portfolio of neoantigen cancer vaccines to key...
3B Future Health Fund announces new investment in iOnctura
14. Juli 2020 03:00 ET
|
Helsinn Healthcare S.A.
3B Future Health Fund announces new investment in iOnctura MONACO, PRINCIPALITY OF MONACO, July 14, 2020: 3B Future Health Fund, previously known as Helsinn Investment Fund S.A., SICAR, today...